Platform Our Approach Mission Pricing About Book Demo

FREQUENTLY ASKED QUESTIONS

Everything You Want to Know
Before You Apply.

Twenty questions from functional medicine practitioners exploring VitalMatrix™ for the first time. If your question is not here, contact us directly or book a discovery call.

Phase 1 · 10 Founding Practitioners · UK Only · ICO ZC101813

ABOUT VITALMATRIX™

What Is VitalMatrix™?

A1. What is VitalMatrix™?
VitalMatrix™ is a clinical intelligence platform built for functional medicine practitioners. It processes patient intake data, biomarkers, and medication history to generate structured terrain-based clinical intelligence outputs. The platform maps dysfunction across five NCZ™ convergence zones, formally designates the Driver using DRD™, and sequences examination priorities through APEX™ (Assessment Priority and Evidence Xray). All outputs are working documents for practitioner review: clinical authority remains with you throughout.
A2. Who is VitalMatrix™ designed for?
VitalMatrix™ is designed exclusively for UK-based functional medicine practitioners. Phase 1 is restricted to a founding cohort of ten practitioners with functional medicine training and active UK clinical registration. The platform is not available directly to patients or the public: every output passes through a practitioner review gate before it can influence patient care.
A3. How is VitalMatrix™ different from general AI tools?
General-purpose AI tools reset between sessions, apply population reference ranges, and produce outputs that require extensive manual correction before they are clinically usable. VitalMatrix™ uses a purpose-built five-layer architecture (FLINT™ Terrain Intelligence Layers) with functional optimal ranges applied by default, terrain-based output language as the native register, evidence tier labelling on every clinical claim, and a mandatory practitioner review gate on all outputs. The intelligence is in the architecture, not in the prompt.
A4. Does VitalMatrix™ replace functional medicine training?
No. VitalMatrix™ is built to amplify functional medicine methodology, not replace it. The platform is Functional Medicine Framework Compatible: it encodes the structured clinical reasoning that experienced practitioners already apply and gives that reasoning a defensible, reproducible documentation infrastructure. Practitioners bring the clinical judgement. VitalMatrix™ provides the terrain intelligence that supports it.

THE PLATFORM

How Does It Work?

B1. What is the FLINT™ framework?
FLINT™ Terrain Intelligence Layers is the five-layer clinical architecture that underlies VitalMatrix™. Layer 1 maps dysfunction across seven biological nodes. Layer 2 identifies which of five NCZ™ convergence zones are active. Layer 3 uses CascadeIQ™ to map how those zones are connected and the direction dysfunction is moving between them. Layer 4 uses DRD™ to formally designate the Driver. Layer 5 uses APEX™ (Assessment Priority and Evidence Xray) to sequence examination priorities by causality, not severity.
B2. What is terrain intelligence?
Terrain intelligence is the structured mapping of biological dysfunction across interconnected physiological systems, with formal designation of which system is driving the pattern and the velocity at which it is moving. The terrain approach does not categorise patients by type: it maps the specific cascade that is active for this patient, at this point in time, and generates clinical outputs calibrated to that map. (The individual clinical relationships systematised by VitalMatrix™ are drawn from established published science. Evidence tier: Established.)
B3. What are the five zones of the NCZ™?
The NCZ™ (Node-Cascade Zone) architecture identifies five clinically significant zones where dysfunction across biological nodes converges and amplifies. Zone 1 is the Metabolic Energy Axis. Zone 2 is the Resilience Network. Zone 3 is the Cardiovascular-Neural Axis. Zone 4 is the Detoxification Trident. Zone 5 is the Hormonal Terrain Axis. Each zone carries an activation threshold: Zone 5 uses a lower threshold reflecting hormonal terrain sensitivity. (Evidence tier: Observed in practice: 26-year clinical observation, Dr Faisal.)
B4. What is the ORBIT™ workflow?
ORBIT™ is the clinical workflow architecture of VitalMatrix™, structuring how patient data moves through the platform from intake to output. ORBIT™ defines the sequence in which terrain assessment, zone scoring, cascade mapping, burden designation, and examination prioritisation occur within a consultation session. Full ORBIT™ workflow detail is available to founding practitioners during the discovery call and onboarding process.
B5. What are the five clinical outputs?
VitalMatrix™ generates five structured clinical outputs from a single patient data input: the Consultation Note, the Phased Personalised Terrain Management Protocol document, the Patient-Facing Summary, the Functional Lab Interpretation Report, and the Session Governance Record. All five are working documents, reviewed and approved by the practitioner before they influence patient care.
Programme and Pricing

FOUNDING PROGRAMME AND PRICING

What Does Phase 1 Involve?

C1. What is the Founding Practitioner Programme?
The Founding Practitioner Programme is the Phase 1 access structure for VitalMatrix™. It comprises two cohorts: Cohort A (Founding Clinical Fellows), which is invitation-only with no monthly fee, and Cohort B (Founding Practitioners), which is application-based at GBP 299 per month. Both cohorts carry a co-development role: founding practitioners provide clinical feedback that directly shapes the platform architecture, scoring logic, and output quality. There are ten slots across both cohorts combined.
C2. What does Cohort B membership include?
Cohort B membership gives you full access to all Phase 1 platform capabilities at GBP 299 per month. This includes NCZ™ zone mapping, Driver identification (DRD™), APEX™ examination prioritisation, CascadeIQ™ cascade architecture, DeltaScan™ follow-up comparison, TIQ™ terrain scoring, TRACE™ timeline analysis, and CZR™ report generation. You also receive a 14-day free trial with opt-out, a 28-day money-back guarantee, and a 5-year price guarantee at GBP 299 per month.
C3. Is there a long-term contract?
Cohort B membership includes a 5-year price guarantee at GBP 299 per month: your rate does not increase during that period regardless of what future pricing becomes for non-founding practitioners. You are not locked in: the 14-day free trial and 28-day money-back guarantee give you a clear exit window if the platform does not meet your clinical requirements. Full terms are covered during the discovery call.
C4. What is the pricing after the 5-year guarantee period?
The pricing structure after the 5-year guarantee period has not been set. VitalMatrix™ is committed to treating founding practitioners fairly: the 5-year guarantee is a binding commitment, and any future pricing changes will be communicated well in advance. What is confirmed is that founding practitioners will never be worse off than practitioners who join after Phase 1.

CLINICAL GOVERNANCE

How Is the Platform Governed?

D1. What is VitalMatrix™'s regulatory status?
VitalMatrix™ is preparing for MHRA Software as a Medical Device (SaMD) classification assessment. The platform generates terrain intelligence working documents for practitioner review and does not prescribe or replace clinical judgement. All outputs carry a practitioner review gate and are framed as Personalised Terrain Management Protocol, not clinical protocols. ICO registration is confirmed: ZC101813.
D2. Does VitalMatrix™ provide a clinical assessment?
No. VitalMatrix™ does not generate, imply, or approximate a clinical assessment at any point. The platform maps terrain burden across convergence zones and designates the Driver to support practitioner decision-making. Every output is explicitly framed as a terrain support consideration for practitioner review. The practitioner applies independent clinical judgement to every output before it reaches a patient: VitalMatrix™ never overrides that authority.
D3. How is patient data handled?
VitalMatrix™ is registered with the ICO (ZC101813). Patient data is processed in compliance with UK GDPR and the Data Protection Act 2018. All patient references within the platform use pseudonymised identifiers: no directly identifying information appears in generated outputs. Practitioners are responsible for obtaining appropriate consent for AI-assisted clinical documentation, and the platform flags this requirement within the workflow.
D4. Can outputs be placed directly in a patient record?
VitalMatrix™ outputs are working documents designed to support practitioner clinical records, not to replace practitioner-authored documentation. The practitioner reviews, approves, and takes clinical responsibility for any output before it enters the patient record. The Session Governance Record maintains an audit trail of the terrain map, zone status, DRD™ burden designation reasoning, and practitioner review timestamps, supporting defensible record-keeping. Consult your medical defence organisation regarding the use of AI-assisted documentation in specific clinical record contexts.

GETTING STARTED

How Do I Join Phase 1?

E1. How do I apply for Cohort B?
Apply via the discovery call booking page at vitalmatrix.co.uk/book/. The discovery call is a 30-minute walkthrough of all Phase 1 capabilities applied to a complex patient case: no obligation to proceed. If the platform meets your clinical requirements, an application and confidentiality framework follows. There are ten founding slots across both cohorts, and a number of those are already allocated.
E2. What happens at the discovery call?
The discovery call is a peer-to-peer clinical walkthrough, not a sales presentation. You will see all Phase 1 capabilities running on a complex patient case: zone mapping, cascade architecture, burden designation, examination prioritisation, and output generation. You will have time to ask clinical questions, stress-test the logic, and determine whether the platform adds value to your existing practice infrastructure. The call runs to 30 minutes and carries no obligation.
E3. Is Phase 1 restricted to UK practitioners?
Yes. Phase 1 is limited to UK-based functional medicine practitioners. The regulatory framework (GMC, MHRA, ICO) is UK-specific, and the founding cohort structure is designed to operate within that framework. International expansion is planned for later phases: practitioners outside the UK are welcome to register interest for future cohort notifications.

STILL HAVE QUESTIONS?

Talk to Dr Faisal Directly

Every practitioner enquiry during Phase 1 is answered personally. No sales team. No automation. No obligation.

Book a Clinical Walkthrough Get in Touch

30 minutes · No obligation · Platform demonstration included

Explore Further

The Case

Why VitalMatrix

The verified gap. The sequencing question answered.

Platform

How It Works

The FLINT™ five-layer pipeline. One intake, five outputs.

Governance

Trust and Safety

MHRA, ICO, data governance, and regulatory status.